Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog and search the HCV drug pipeline click here; for more information on HCV clinical trials click here
Be sure to check out our other blog: Hepatitis & Tattoos
Drugs in Development / Clinical Trials—Updated May 18, 2013
Saturday, May 18, 2013
Researchers from the Marshfield Clinic in Wisconsin conducted a meta-analysis that included 19 case-control studies performed throughout the world. The analysis included a total of 13,947 cases and 1,559,448 controls. In nine of the studies, the controls were non-lymphoma cancer/hospital patients; eight studies incorporated healthy controls, and two studies included both types of controls. In most of the studies (17), patients were diagnosed with hepatitis B by detection of HBsAg, while hepatitis B was self-reported in the remaining two studies. All incidences of non-hodgkin lymphoma (NHL) were diagnosed with histopathology.
Thursday, May 16, 2013
Hepatitis C infections unknown to many of those infected and treatment rates are low(dailyRx News) Hepatitis C is a term many people are familiar with, but don’t really devote much thought to – and that may represent part of a very serious problem.
A new report in the New England Journal of Medicine stated that only around half of people infected with hepatitis C are aware they are infected, with even fewer people being referred to medical care — and still fewer being successfully treated.
"Ask your doctor if you should be tested for Hep C."
NKY Health Department offers vaccines programNorthern Kentucky Health Department is offering vaccines to people at high risk for hepatitis B as the region fights a rise in diagnoses of the disease.
Those who qualify will receive a series of three vaccines over six months at a low cost, thanks to a Kentucky Department for Public Health grant, said Joyce Rice, epidemiology manager for the NKY Health Department.
Triple therapy for hepatitis C is effective after liver transplantation, but side-effects are common
While many hepatitis C patients await interferon-free direct-acting antiviral regimens, others have advanced liver disease and need treatment now. This group includes liver transplant recipients, as HCV almost always recurs and infects the new liver in the absence of treatment.
Elizabeth Verna from Columbia University and fellow investigators with the CRUSH-C study evaluated triple therapy in a cohort of liver transplant recipients at six US centres.
Wednesday, May 15, 2013
- Waiakea Health Center at 191 Kuawa St. in Hilo, for hepatitis B and C. Call 974-4247 for an appointment.
- Hawaii Island HIV/AIDS Foundation at 16-204 Melekahiwa Pl., #1, in Keaau, for hepatitis C only. Open from 9 a.m. to 3 p.m. Call 982-8800 for information.
- Hawaii Island HIV/AIDS Foundation at 75-240 Nani Kailua Dr., #5, in Kailua-Kona, for hepatitis C only. Open from 9 a.m. to 3 p.m. Call 331-8177 for information.
The free hepatitis C testing is now available at the ASG offices on 10th Street in Charlottesville, as well as out in the community.
The park is located at 6 Gilchrest Road in Congers and the rain date is Sunday, May 19.